Skip to main content

05.05.2023 | Research

Cardiovascular Manifestations of Turner Syndrome: Phenotypic Differences Between Karyotype Subtypes

verfasst von: Alona Birjiniuk, Allison Goetsch Weisman, Christina Laternser, Joseph Camarda, Wendy J. Brickman, Reema Habiby, Sheetal R. Patel

Erschienen in: Pediatric Cardiology

Einloggen, um Zugang zu erhalten

Abstract

Turner syndrome (TS) is a genetic disorder presenting in phenotypic females with total or partial monosomy of the X chromosome. Cardiovascular abnormalities are common, including congenital heart defects (CHD) and aortic dilation. Although mosaic TS is suspected to have less severe phenotype as compared to non-mosaic TS, differences in cardiovascular manifestations between karyotypes are not well studied. This is a single-center retrospective cohort study including patients with TS seen from 2000 to 2022. Demographic data, chromosomal analysis, and imaging were reviewed. Karyotypes were categorized as monosomy X (45X), 45X mosaicism, isochromosome Xq, partial X deletions, ring X (r(X)), TS with Y material, and others. Prevalence of CHD and aortic dilation were compared between monosomy X and other subtypes using Pearson’s chi-square test and Welch two-sample t-test. We included 182 TS patients with median age 18 (range 4–33) years. CHD was more common in monosomy X as compared with others (61.4% vs. 26.8%, p < 0.001), including bicuspid aortic valve (44.3% vs. 16.1%, p < 0.001), partial anomalous pulmonary venous return (12.9% vs. 2.7%, p = 0.023), persistent left superior vena cava (12.9% vs. 1.8%, p = 0.008), and coarctation of the aorta (20.0% vs. 4.5%, p = 0.003). Cardiac surgery (24.3% vs. 8.9%, p = 0.017) was more prevalent in the monosomy X group. There was no statistically significant difference for presence of aortic dilation (7.1% vs 1.8%, p = 0.187). Although CHD and need for cardiac surgery are more common in TS with monosomy X as compared to others, all TS subtypes may have similar risk of developing aortic dilation. All TS patients should have similar cardiovascular surveillance testing to monitor for aortic dilation.
Literatur
1.
Zurück zum Zitat Bondy CA (2007) Care of girls and women with turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab 92:10–25CrossRefPubMed Bondy CA (2007) Care of girls and women with turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab 92:10–25CrossRefPubMed
3.
Zurück zum Zitat Duijnhouwer AL, Bons LR, Timmers HJLM, van Kimmenade RRL, Snoeren M, Timmermans J, van den Hoven AT, Kempers M, van Dijk APJ, Fleischer K, Roos-Hesselink JW (2019) Aortic dilatation and outcome in women with Turner syndrome. Heart 105:693–700CrossRefPubMed Duijnhouwer AL, Bons LR, Timmers HJLM, van Kimmenade RRL, Snoeren M, Timmermans J, van den Hoven AT, Kempers M, van Dijk APJ, Fleischer K, Roos-Hesselink JW (2019) Aortic dilatation and outcome in women with Turner syndrome. Heart 105:693–700CrossRefPubMed
4.
Zurück zum Zitat Kim HK, Gottliebson W, Hor K, Backeljauw P, Gutmark-Little I, Salisbury SR, Racadio JM, Helton-Skally K, Fleck R (2011) Cardiovascular anomalies in turner syndrome: spectrum, prevalence, and cardiac mri findings in a pediatric and young adult population. Am J Roentgenol 196:454–460CrossRef Kim HK, Gottliebson W, Hor K, Backeljauw P, Gutmark-Little I, Salisbury SR, Racadio JM, Helton-Skally K, Fleck R (2011) Cardiovascular anomalies in turner syndrome: spectrum, prevalence, and cardiac mri findings in a pediatric and young adult population. Am J Roentgenol 196:454–460CrossRef
5.
Zurück zum Zitat Lopez L, Arheart KL, Colan SD, Stein NS, Lopez-Mitnik G, Lin AE, Reller MD, Ventura R, Silberbach M (2008) Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics 121:e1622–e1627CrossRefPubMed Lopez L, Arheart KL, Colan SD, Stein NS, Lopez-Mitnik G, Lin AE, Reller MD, Ventura R, Silberbach M (2008) Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics 121:e1622–e1627CrossRefPubMed
6.
Zurück zum Zitat Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, Sandberg DE, Sas TCJ, Silberbach M, Söderström-Anttila V, Stochholm K, van Alfen-van derVelden JA, Woelfle J, Backeljauw PF (2017) Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner syndrome meeting. Eur J Endocrinol 177:G1–G70CrossRefPubMed Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, Sandberg DE, Sas TCJ, Silberbach M, Söderström-Anttila V, Stochholm K, van Alfen-van derVelden JA, Woelfle J, Backeljauw PF (2017) Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner syndrome meeting. Eur J Endocrinol 177:G1–G70CrossRefPubMed
7.
Zurück zum Zitat Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, Backer JD, Eagle KA, Hiratzka LF, Johnson WH, Kadian-Dodov D, Lopez L, Mortensen KH, Prakash SK, Ratchford EV, Saidi A, Iv H, Young LT (2018) Cardiovascular health in turner syndrome: a scientific statement from the american heart association. Circulation 11:e000048PubMed Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, Backer JD, Eagle KA, Hiratzka LF, Johnson WH, Kadian-Dodov D, Lopez L, Mortensen KH, Prakash SK, Ratchford EV, Saidi A, Iv H, Young LT (2018) Cardiovascular health in turner syndrome: a scientific statement from the american heart association. Circulation 11:e000048PubMed
8.
Zurück zum Zitat Quezada E, Lapidus J, Shaughnessy R, Chen Z, Silberbach M (2015) Aortic dimensions in Turner syndrome. Am J Med Genet A 167:2527–2532CrossRef Quezada E, Lapidus J, Shaughnessy R, Chen Z, Silberbach M (2015) Aortic dimensions in Turner syndrome. Am J Med Genet A 167:2527–2532CrossRef
9.
Zurück zum Zitat Cameron- Pimblett A, La Rosa C, King TFJ, Davies MC, Conway GS (2017) The Turner syndrome life course project: Karyotype-phenotype analyses across the lifespan. Clin Endocrinol 87:532–538CrossRef Cameron- Pimblett A, La Rosa C, King TFJ, Davies MC, Conway GS (2017) The Turner syndrome life course project: Karyotype-phenotype analyses across the lifespan. Clin Endocrinol 87:532–538CrossRef
10.
Zurück zum Zitat Chou Y-Y, Wang C-J, Lin C-H, Chung H-T, Lo F-S (2020) Association between cardiovascular anomalies and karyotypes in Turner syndrome patients in Taiwan: a local cohort study. Pediatr Neonatol 61:188–194CrossRefPubMed Chou Y-Y, Wang C-J, Lin C-H, Chung H-T, Lo F-S (2020) Association between cardiovascular anomalies and karyotypes in Turner syndrome patients in Taiwan: a local cohort study. Pediatr Neonatol 61:188–194CrossRefPubMed
11.
Zurück zum Zitat Snyder EA, San Roman AK, Piña-Aguilar RE, Steeves MA, McNamara EA, Souter I, Hayes FJ, Levitsky LL, Lin AE (2021) Genetic counseling for women with 45, X/46, XX mosaicism: towards more personalized management. Eur J Med Genet 64:104140CrossRefPubMed Snyder EA, San Roman AK, Piña-Aguilar RE, Steeves MA, McNamara EA, Souter I, Hayes FJ, Levitsky LL, Lin AE (2021) Genetic counseling for women with 45, X/46, XX mosaicism: towards more personalized management. Eur J Med Genet 64:104140CrossRefPubMed
12.
Zurück zum Zitat Noordman I, Duijnhouwer A, Kapusta L, Kempers M, Roeleveld N, Schokking M, Smeets D, Freriks K, Timmers H, van Alfen-van der Velden J (2018) Phenotype in girls and women with Turner syndrome: association between dysmorphic features, karyotype and cardio-aortic malformations. Eur J Med Genet 61:301–306CrossRefPubMed Noordman I, Duijnhouwer A, Kapusta L, Kempers M, Roeleveld N, Schokking M, Smeets D, Freriks K, Timmers H, van Alfen-van der Velden J (2018) Phenotype in girls and women with Turner syndrome: association between dysmorphic features, karyotype and cardio-aortic malformations. Eur J Med Genet 61:301–306CrossRefPubMed
13.
Zurück zum Zitat Noordman ID, Fejzic Z, Bos M, Duijnhouwer AL, Weijers G, Kempers M, Merkx R, van der Velden JAEM, Kapusta L (2021) Cardiac abnormalities in girls with Turner syndrome: ECG abnormalities, myocardial strain imaging, and karyotype–phenotype associations. Am J Med Genet A 185:2399–2408CrossRefPubMedPubMedCentral Noordman ID, Fejzic Z, Bos M, Duijnhouwer AL, Weijers G, Kempers M, Merkx R, van der Velden JAEM, Kapusta L (2021) Cardiac abnormalities in girls with Turner syndrome: ECG abnormalities, myocardial strain imaging, and karyotype–phenotype associations. Am J Med Genet A 185:2399–2408CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Wolff DJ, Van Dyke DL, Powell CM, Committee AWGotALQA (2010) Laboratory guideline for Turner syndrome. Genet Med 12:52–55CrossRefPubMed Wolff DJ, Van Dyke DL, Powell CM, Committee AWGotALQA (2010) Laboratory guideline for Turner syndrome. Genet Med 12:52–55CrossRefPubMed
15.
Zurück zum Zitat StataCorp (2015) Stata Statistical Software: Release 14. StataCorp LLC, College Station, TX StataCorp (2015) Stata Statistical Software: Release 14. StataCorp LLC, College Station, TX
16.
Zurück zum Zitat StataCorp (2021) Stata Statistical Software: Release 17. StataCorp LLC, College Station, TX StataCorp (2021) Stata Statistical Software: Release 17. StataCorp LLC, College Station, TX
17.
Zurück zum Zitat Fiot E, Zénaty D, Boizeau P, Haignere J, Dos Santos S, Léger J, Carel JC, Cabrol S, Chanson P, Christin-Maitre S, Courtillot C, Donadille B, Dulon J, Houang M, Nedelcu M, Netchine I, Polak M, Salenave S, Samara-Boustani D, Simon D, Touraine P, Viaud M, Bony H, Braun K, Desailloud R, Bertrand AM, Mignot B, Schillo F, Barat P, Kerlan V, Metz C, Sonnet E, Reznik Y, Ribault V, Carla H, Tauveron I, Bensignor C, Huet F, Verges B, Chabre O, Dupuis C, Spiteri A, Cartigny M, Stuckens C, Weill J, Lienhardt A, Naud-Saudreau C, Borson-Chazot F, Brac de la Perriere A, Pugeat M, Brue T, Reynaud R, Simonin G, Paris F, Sultan C, Leheup B, Weryha G, Baron S, Charbonnel B, Dubourdieu S, Baechler E, Fenichel P, Wagner K, Compain F, Crosnier H, Personnier C, Delemer B, Hecart AC, Souchon PF, De Kerdanet M, Galland F, Nivot-Adamiak S, Castanet M, Lecointre C, Richard O, Jeandidier N, Soskin S, Lecomte P, Pepin-Donat M, Pierre P (2019) X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood. Eur J Endocrinol 180:397–406CrossRefPubMed Fiot E, Zénaty D, Boizeau P, Haignere J, Dos Santos S, Léger J, Carel JC, Cabrol S, Chanson P, Christin-Maitre S, Courtillot C, Donadille B, Dulon J, Houang M, Nedelcu M, Netchine I, Polak M, Salenave S, Samara-Boustani D, Simon D, Touraine P, Viaud M, Bony H, Braun K, Desailloud R, Bertrand AM, Mignot B, Schillo F, Barat P, Kerlan V, Metz C, Sonnet E, Reznik Y, Ribault V, Carla H, Tauveron I, Bensignor C, Huet F, Verges B, Chabre O, Dupuis C, Spiteri A, Cartigny M, Stuckens C, Weill J, Lienhardt A, Naud-Saudreau C, Borson-Chazot F, Brac de la Perriere A, Pugeat M, Brue T, Reynaud R, Simonin G, Paris F, Sultan C, Leheup B, Weryha G, Baron S, Charbonnel B, Dubourdieu S, Baechler E, Fenichel P, Wagner K, Compain F, Crosnier H, Personnier C, Delemer B, Hecart AC, Souchon PF, De Kerdanet M, Galland F, Nivot-Adamiak S, Castanet M, Lecointre C, Richard O, Jeandidier N, Soskin S, Lecomte P, Pepin-Donat M, Pierre P (2019) X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood. Eur J Endocrinol 180:397–406CrossRefPubMed
18.
Zurück zum Zitat Viuff M, Skakkebæk A, Nielsen MM, Chang S, Gravholt CH (2019) Epigenetics and genomics in Turner syndrome. Am J Med Genet C Semin Med Genet 181:125–132CrossRef Viuff M, Skakkebæk A, Nielsen MM, Chang S, Gravholt CH (2019) Epigenetics and genomics in Turner syndrome. Am J Med Genet C Semin Med Genet 181:125–132CrossRef
19.
Zurück zum Zitat Bondy CA (2008) Congenital cardiovascular disease in Turner syndrome. Congenit Heart Dis 3:2–15CrossRefPubMed Bondy CA (2008) Congenital cardiovascular disease in Turner syndrome. Congenit Heart Dis 3:2–15CrossRefPubMed
20.
Zurück zum Zitat El-Mansoury M, Barrenäs M-L, Bryman I, Hanson C, Larsson C, Wilhelmsen L, Landin-Wilhelmsen K (2007) Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome. Clin Endocrinol 66:744–751CrossRef El-Mansoury M, Barrenäs M-L, Bryman I, Hanson C, Larsson C, Wilhelmsen L, Landin-Wilhelmsen K (2007) Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome. Clin Endocrinol 66:744–751CrossRef
21.
Zurück zum Zitat Turtle EJ, Sule AA, Bath LE, Denvir M, Gebbie A, Mirsadraee S, Webb DJ (2013) Assessing and addressing cardiovascular risk in adults with Turner syndrome. Clin Endocrinol (Oxf) 78:639–645CrossRefPubMed Turtle EJ, Sule AA, Bath LE, Denvir M, Gebbie A, Mirsadraee S, Webb DJ (2013) Assessing and addressing cardiovascular risk in adults with Turner syndrome. Clin Endocrinol (Oxf) 78:639–645CrossRefPubMed
22.
Zurück zum Zitat Cleemann L, Mortensen KH, Holm K, Smedegaard H, Skouby SO, Wieslander SB, Leffers AM, Leth-Espensen P, Pedersen EM, Gravholt CH (2010) Aortic dimensions in girls and young women with turner syndrome: a magnetic resonance imaging study. Pediatr Cardiol 31:497–504CrossRefPubMed Cleemann L, Mortensen KH, Holm K, Smedegaard H, Skouby SO, Wieslander SB, Leffers AM, Leth-Espensen P, Pedersen EM, Gravholt CH (2010) Aortic dimensions in girls and young women with turner syndrome: a magnetic resonance imaging study. Pediatr Cardiol 31:497–504CrossRefPubMed
Metadaten
Titel
Cardiovascular Manifestations of Turner Syndrome: Phenotypic Differences Between Karyotype Subtypes
verfasst von
Alona Birjiniuk
Allison Goetsch Weisman
Christina Laternser
Joseph Camarda
Wendy J. Brickman
Reema Habiby
Sheetal R. Patel
Publikationsdatum
05.05.2023
Verlag
Springer US
Erschienen in
Pediatric Cardiology
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-023-03159-0

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.